New Epigenetic Regulation of Cancer Uncovered
Scientists have identified a new gene that can inhibit a multi-protein complex, possibly increasing the risk of cancer, according to a new study published in Science Advances.
Browsing: "Research"
Created for Collaboration
The Simpson Querrey Biomedical Research Center, which officially opened in mid-June, is designed to maximize collaboration and multi-disciplinary research efforts.
Slowing Metabolism Can Prevent Detrimental Effects of Genetic Mutations
Slowing mutant fruit flies’ metabolic rates can prevent detrimental effects of many genetic mutations, according a new study published in the journal Cell.
Medical Student Pursues Glioblastoma Treatments in the Lab
Medical student Shivani Baisiwala investigates glioblastoma in the laboratory of Atique Ahmed, PhD, while also pursuing pro-bono healthcare consulting and finding time to explore Chicago’s neighborhoods.
Faculty Explore Policy Solutions for Cancer Drug Delivery
Sheetal Kircher, MD, ’11 GME, is laser-focused on cancer drug distribution and pricing: she spent a year as a health policy fellow at the ASCO and published a paper on the topic in JAMA.
Faculty Honored With Presidential Early Career Awards
Two Northwestern Medicine investigators were among five Northwestern University faculty recently awarded the prestigious Presidential Early Career Award for Scientists and Engineers.
Predicting Risk of Disability From Knee Osteoarthritis
Northwestern Medicine scientists have developed and validated a tool to predict which patients with pre-osteoarthritis are at high risk for developing disability in the future.
New Insights Into Role of RNA Methylation in Fragile X Syndrome
Northwestern Medicine scientists have discovered that the protein FMRP — the loss of which leads to Fragile X syndrome — is a novel reader of RNA methylation.
NUCATS Awarded $46 Million to Transform Scientific Discovery Into Treatments
The National Institutes of Health has awarded Northwestern University a five-year, $46 million grant to renew the Northwestern University Clinical and Translational Sciences Institute.
Pancreatic Cancer Drug, High-Fat Diet Linked to Liver Disease Risk
An emerging class of cancer drugs has shown promise in treating pancreatic cancer, but the drugs may cause severe liver damage when combined with high-fat diets, according to study published in PNAS.